Mr. Colm Forde:

Yes. There are different models in different member states. One of the issues that some of our stakeholders have highlighted is that if all of these medicines are now going to require a prescription, the best way of ensuring a competitive supply chain is to break the link between prescribing and dispensing. We committed to examining that as part of the antiparasitic stakeholder group. Some countries do not allow vets to sell medicines and allow them to prescribe only. We said we would examine that as an option.